Improving skin barrier function. 
The skin is our largest organ and protects us from exposure to harsh external environments. Compromised skin barrier function is associated with skin diseases such as ichthyosis, eczema and psoriasis. Although genetically different, these skin conditions may share common symptoms such as redness, itch and discomfort, often resulting in sleep disruption. The psychosocial burdens of skin diseases have also been well documented in the literature and include social isolation, depression as well as decreased quality of life.

TWLX-001 is a development stage program that leverages patent-pending technology to address skin barrier function. 


‍Enhancing delivery of dermatologic pharmaceuticals and skin actives.
Healthy skin protects us from exposure to external toxins. As a result, the accessibility of topically applied skin beneficial actives and pharmaceuticals remains limited.

TWLX-010 is a discovery stage program enabling the enhanced delivery of active compounds to the skin.